UBS Maintains Buy on UnitedHealth Group, Raises Price Target to $460

Benzinga Newsdesk www.benzinga.com Positive 85.4%

Neg 0% Neu 0% Pos 85.4%

UBS analyst A.J. Rice maintains UnitedHealth Group (NYSE:UNH) with a Buy and raises the price target from $410 to $460.

Comments

No comments yet. Be the first!